New Study Introduces Valuable Tool To Aid Doctors And Patients In Choosing Successful Outcomes For Cheek Rejuvenation
"As a surgeon, patient satisfaction is my most important goal," says Jacono. "While many patients require a multi-faceted surgical approach in order to see successful results, we recognize that many patients may be adverse to certain procedures, or financially limited. We hope that this valuable tool will assist aesthetic surgeons and patients in having critical conversations that result in selection of the best plan possible."
About Dr. Andrew Jacono A Dual Board Certified, Facial Plastic and Reconstructive Surgeon with offices in Manhattan and Great Neck, NY, Dr. Andrew Jacono is Section Head of Facial Plastic and Reconstructive Surgery at North Shore University Hospital Manhasset, Assistant Clinical Professor, Division of Facial Plastic and Reconstructive Surgery at The New York Eye and Ear Infirmary and Director of The New York Center for Facial Plastic & Laser Surgery in Great Neck, NY. His recently released second book is titled The Face of the Future – Look Natural, Not Plastic: A Less-invasive Approach to Enhance Your Beauty and Reverse Facial Aging and he is the creator of J PAK SYSTEMS – convenient, homeopathic remedies to help optimize healing after aesthetic injectable and surgical procedures.
With surgical privileges at six New York area hospitals, an extensive background in Head and Neck Surgery with subspecialty training in Facial Plastic Surgery, Dr. Jacono is recognized amongst his peers for his innovative surgical techniques and skills. His clinical research has been presented at several national meetings and symposiums and he has authored numerous manuscripts and published articles in leading medical journals on a variety of surgical techniques, including minimally invasive endoscopic facial plastic surgery and lip augmentation.
To learn more about Dr. Jacono and his practice, visit www.newyorkfacialplasticsurgery.com.SOURCE New York Center for Facial Plastic and Laser Surgery
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts